hood cpap Search Results


cpap hood  (STARmed Co Ltd)
90
STARmed Co Ltd cpap hood
Cpap Hood, supplied by STARmed Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hood+cpap/pm25342655-32-110-145?v=STARmed+Co+Ltd
Average 90 stars, based on 1 article reviews
cpap hood - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
helmet cpap (castar hood cpap therapy  (Intersurgical inc)
90
Intersurgical inc helmet cpap (castar hood cpap therapy
Helmet Cpap (Castar Hood Cpap Therapy, supplied by Intersurgical inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hood+cpap/ppr0234824-57-0-14?v=Intersurgical+inc
Average 90 stars, based on 1 article reviews
helmet cpap (castar hood cpap therapy - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
helmet cpap castar hood for cpap therapy  (Intersurgical inc)
90
Intersurgical inc helmet cpap castar hood for cpap therapy
Participant timeline. Patients in the medical intermediate COVID-19 cohort ward will be screened for eligibility according to the inclusion and exclusion criteria, given written and oral information and then asked for written informed consent. Secondary endpoints will be collected at 1 h, 24 h and 28 days from randomisation, when the primary endpoint of ventilator-free days will also be assessed. We plan to include 60 patients in each group and expect the HFNC group to have ~ 19.5 VFD and the <t>Helmet</t> <t>CPAP</t> group to have ~ 23.3 VFD at 28 days. The thickness of the lines corresponds to the expected patient density in intervention versus control group and treatment in ward versus intensive care and in patients who survive or die within 28 days from randomisation. Abbreviations: SpO2, peripheral oxygen saturation; FiO2 ratio, fractional inspired oxygen concentration; RR, respiratory rate; PEEP, positive expiratory end-pressure; NEWS, national early warning score; AE, adverse events; VFD, ventilator-free days (within 28 days); ICU, intensive care unit; CPAP, continuous positive airway pressure
Helmet Cpap Castar Hood For Cpap Therapy, supplied by Intersurgical inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hood+cpap/pmc07711053-47-0-8?v=Intersurgical+inc
Average 90 stars, based on 1 article reviews
helmet cpap castar hood for cpap therapy - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
castar hood for cpap therapy, infant type  (STARmed Co Ltd)
90
STARmed Co Ltd castar hood for cpap therapy, infant type
Participant timeline. Patients in the medical intermediate COVID-19 cohort ward will be screened for eligibility according to the inclusion and exclusion criteria, given written and oral information and then asked for written informed consent. Secondary endpoints will be collected at 1 h, 24 h and 28 days from randomisation, when the primary endpoint of ventilator-free days will also be assessed. We plan to include 60 patients in each group and expect the HFNC group to have ~ 19.5 VFD and the <t>Helmet</t> <t>CPAP</t> group to have ~ 23.3 VFD at 28 days. The thickness of the lines corresponds to the expected patient density in intervention versus control group and treatment in ward versus intensive care and in patients who survive or die within 28 days from randomisation. Abbreviations: SpO2, peripheral oxygen saturation; FiO2 ratio, fractional inspired oxygen concentration; RR, respiratory rate; PEEP, positive expiratory end-pressure; NEWS, national early warning score; AE, adverse events; VFD, ventilator-free days (within 28 days); ICU, intensive care unit; CPAP, continuous positive airway pressure
Castar Hood For Cpap Therapy, Infant Type, supplied by STARmed Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hood+cpap/pm34861639-65-7-38?v=STARmed+Co+Ltd
Average 90 stars, based on 1 article reviews
castar hood for cpap therapy, infant type - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Participant timeline. Patients in the medical intermediate COVID-19 cohort ward will be screened for eligibility according to the inclusion and exclusion criteria, given written and oral information and then asked for written informed consent. Secondary endpoints will be collected at 1 h, 24 h and 28 days from randomisation, when the primary endpoint of ventilator-free days will also be assessed. We plan to include 60 patients in each group and expect the HFNC group to have ~ 19.5 VFD and the Helmet CPAP group to have ~ 23.3 VFD at 28 days. The thickness of the lines corresponds to the expected patient density in intervention versus control group and treatment in ward versus intensive care and in patients who survive or die within 28 days from randomisation. Abbreviations: SpO2, peripheral oxygen saturation; FiO2 ratio, fractional inspired oxygen concentration; RR, respiratory rate; PEEP, positive expiratory end-pressure; NEWS, national early warning score; AE, adverse events; VFD, ventilator-free days (within 28 days); ICU, intensive care unit; CPAP, continuous positive airway pressure

Journal: Trials

Article Title: Helmet continuous positive airway pressure versus high-flow nasal cannula in COVID-19: a pragmatic randomised clinical trial (COVID HELMET)

doi: 10.1186/s13063-020-04863-5

Figure Lengend Snippet: Participant timeline. Patients in the medical intermediate COVID-19 cohort ward will be screened for eligibility according to the inclusion and exclusion criteria, given written and oral information and then asked for written informed consent. Secondary endpoints will be collected at 1 h, 24 h and 28 days from randomisation, when the primary endpoint of ventilator-free days will also be assessed. We plan to include 60 patients in each group and expect the HFNC group to have ~ 19.5 VFD and the Helmet CPAP group to have ~ 23.3 VFD at 28 days. The thickness of the lines corresponds to the expected patient density in intervention versus control group and treatment in ward versus intensive care and in patients who survive or die within 28 days from randomisation. Abbreviations: SpO2, peripheral oxygen saturation; FiO2 ratio, fractional inspired oxygen concentration; RR, respiratory rate; PEEP, positive expiratory end-pressure; NEWS, national early warning score; AE, adverse events; VFD, ventilator-free days (within 28 days); ICU, intensive care unit; CPAP, continuous positive airway pressure

Article Snippet: Helmet CPAP (CaStar hood for CPAP therapy by Starmed/Intersurgical) driven by high-flow blender (Bio-Med Devices).

Techniques: Control, Concentration Assay

Journal: Trials

Article Title: Helmet continuous positive airway pressure versus high-flow nasal cannula in COVID-19: a pragmatic randomised clinical trial (COVID HELMET)

doi: 10.1186/s13063-020-04863-5

Figure Lengend Snippet:

Article Snippet: Helmet CPAP (CaStar hood for CPAP therapy by Starmed/Intersurgical) driven by high-flow blender (Bio-Med Devices).

Techniques: Infection